Skip to main content
OpenTrials

Clinical trial condition

Dermatitis

Explore clinical trials studying Dermatitis. Study availability and eligibility vary by location and protocol.

1,525 public trials 180 recruiting studies
Refine in advanced search Browse all conditions

Dermatitis trial results

Completed

Efficacy and Safety of Roflumilast Cream in Subjects With Atopic Dermatitis

NCT06631170

Conditions
Atopic Dermatitis (AD), Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • The Second affiliated Hospital of Wannan Medical College Wuhu, Anhui, China
  • Beijing Aerospace General Hospital Beijing, Beijing Municipality, China
  • Beijing Children's Hospital Beijing, Beijing Municipality, China
  • Beijing Tongren Hospital, CMU Beijing, Beijing Municipality, China
View all 61 locations
View Trial Details
Completed

Clinical Effect, Safety and Tolerability of GSK1070806 in Atopic Dermatitis

NCT04975438

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +8 more
Locations
  • GSK Investigational Site North Little Rock, Arkansas, United States
  • GSK Investigational Site Miami, Florida, United States
  • GSK Investigational Site Tampa, Florida, United States
  • GSK Investigational Site Troy, Michigan, United States
View Trial Details
Completed

Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of EP262 in Subjects With Atopic Dermatitis

NCT06144424

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Allervie Clinical Research Birmingham, Alabama, United States
  • RM Medical Research, Inc. Miami Lakes, Florida, United States
  • Indiana Clinical Trials Center Plainfield, Indiana, United States
  • Lawrence J. Green, MD LLC Rockville, Maryland, United States
View Trial Details
Completed

An Observational Study of Upadacitinib to Assess Change in Disease Activity in Canadian Adult Participants With Moderate-to-Severe Atopic Dermatitis Who Are Inadequate Responders To or Discontinuing Dupilumab

NCT05394792

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Dermatology Research Institute - Blackfoot Trail /ID# 246344 Calgary, Alberta, Canada
  • Laser Rejuvenation Clinics Inc. /ID# 255303 Calgary, Alberta, Canada
  • Rejuvenation Dermatology Clinic Calgary North /ID# 255623 Calgary, Alberta, Canada
  • Rejuvenation Dermatology - Edmonton Downtown /ID# 246298 Edmonton, Alberta, Canada
View all 25 locations
View Trial Details
Completed

A Community-based Assessment of Skin Care, Allergies, and Eczema

NCT03409367

Conditions
Atopic Dermatitis, Atopic Disorders, Atopic Eczema, +12 more
Locations
  • University of Colorado-Denver Denver, Colorado, United States
  • Duke University Durham, North Carolina, United States
  • Oregon Health & Science University Portland, Oregon, United States
  • University of Wisconsin-Madison Madison, Wisconsin, United States
View Trial Details
Completed

Long Term Extension Study of Tapinarof Cream, 1% for Subjects With Atopic Dermatitis

NCT05142774

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Dermavant Investigative Site Birmingham, Alabama, United States
  • Dermavant Investigative Site Phoenix, Arizona, United States
  • Dermavant Investigative Site Scottsdale, Arizona, United States
  • Dermavant Investigative Site Scottsdale, Arizona, United States
View all 112 locations
View Trial Details

Related conditions